Journal of Preventive Medicine and Public Health

  • 제57권3호
  • /
  • Pages.212-222
  • /
  • 2024
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

The Role of Pharmacists' Interventions in Increasing Medication Adherence of Patients With Epilepsy: A Scoping Review

  • Iin Ernawati (Doctoral Program in Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada) ;
  • Nanang Munif Yasin (Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada) ;
  • Ismail Setyopranoto (Department of Neurology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada) ;
  • Zullies Ikawati (Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada)
  • 투고 : 2023.12.22
  • 심사 : 2024.03.31
  • 발행 : 2024.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: Epilepsy is a chronic disease that requires long-term treatment and intervention from health workers. Medication adherence is a factor that influences the success of therapy for patients with epilepsy. Therefore, this study aimed to analyze the role of pharmacists in improving the clinical outcomes of epilepsy patients, focusing on medication adherence. Methods: A scoping literature search was conducted through the ScienceDirect, PubMed, and Google Scholar databases. The literature search included all original articles published in English until August 2023 for which the full text was available. This scoping review was carried out by a team consisting of pharmacists and neurologists following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews and the Joanna Briggs Institute guidelines, including 5 steps: identifying research questions, finding relevant articles, selecting articles, presenting data, and compiling the results. Results: The literature search yielded 10 studies that discussed pharmacist interventions for patients with epilepsy. Five articles described educational interventions involving drug-related counseling with pharmacists. Two articles focused on similar pharmacist interventions through patient education, both verbal and written. Three articles discussed an epilepsy review service, a multidisciplinary intervention program involving pharmacists and other health workers, and a mixed intervention combining education and training with therapy-based behavioral interventions. Conclusions: Pharmacist interventions have been shown to be effective in improving medication adherence in patients with epilepsy. Furthermore, these interventions play a crucial role in improving other therapeutic outcomes, including patients' knowledge of self-management, perceptions of illness, the efficacy of antiepileptic drugs in controlling seizures, and overall quality of life.

키워드

과제정보

This work was supported by the Indonesian Endowment Funds for Education (LPDP) and the Center for Higher Education Funding (BPPT) (No. 202209091837) for financial support for education and research dissertations.

참고문헌

  1. Wirrell EC. Classification of seizures and the epilepsies. In: Cascino GD, Sirven JI, Tatum WO, editors. Epilepsy. 2nd ed. John Wiley & Sons; 2021, p.11-22. https://doi.org/10.1002/9781119431893.ch2
  2. Aminoff M, dan Douglas V. Nervous system disorders. In: Papadakis MA, McPhee SJ, Rabow MW, editors. Current medical diagnosis & treatment. New York: McGraw Hill Education; 2022, p. 987-991.
  3. World Health Organization. Epilepsy; 2023 [cited 2023 Dec 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy
  4. Bonnett LJ, Tudur Smith C, Smith D, Williamson PR, Chadwick D, Marson AG. Time to 12-month remission and treatment failure for generalised and unclassified epilepsy. J Neurol Neurosurg Psychiatry 2014;85(6):603-610. https://doi.org/10.1136/jnnp-2013-306040
  5. French JA, Pedley TA. Clinical practice. Initial management of epilepsy. N Engl J Med 2008;359(2):166-176. https://doi.org/10.1056/NEJMcp0801738
  6. World Health Organization. Adherence to long-term therapies: evidence for action; 2003 [cited 2023 Jul 17]. Available from: https://iris.who.int/handle/10665/42682
  7. AlAjmi R, Al-Aqeel S, Baz S. The impact of a pharmacist-led educational interview on medication adherence of Saudi patients with epilepsy. Patient Prefer Adherence 2017;11:959-964. https://doi.org/10.2147/PPA.S124028
  8. Faught RE, Weiner JR, Guerin A, Cunnington MC, Duh MS. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia 2009;50(3):501-509. https://doi.org/10.1111/j.1528-1167.2008.01794.x
  9. Lie IA, Hoggen I, Samsonsen C, Brodtkorb E. Treatment nonadherence as a trigger for status epilepticus: an observational, retrospective study based on therapeutic drug monitoring. Epilepsy Res 2015;113:28-33. https://doi.org/10.1016/j.eplepsyres.2015.03.007
  10. Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol 2018;75(3):279-286. https://doi.org/10.1001/jamaneurol.2017.3949
  11. Rohde NN, Baca CB, Van Cott AC, Parko KL, Amuan ME, Pugh MJ. Antiepileptic drug prescribing patterns in Iraq and Afghanistan war veterans with epilepsy. Epilepsy Behav 2015;46:133-139. https://doi.org/10.1016/j.yebeh.2015.03.027
  12. Moseley BD, Chanteux H, Nicolas JM, Laloyaux C, Gidal B, Stockis A. A review of the drug-drug interactions of the antiepileptic drug brivaracetam. Epilepsy Res 2020;163:106327. https://doi.org/10.1016/j.eplepsyres.2020.106327
  13. Mutanana N, Tsvere M, Chiweshe MK. General side effects and challenges associated with anti-epilepsy medication: a review of related literature. Afr J Prim Health Care Fam Med 2020;12(1):e1-e5. https://doi.org/10.4102/phcfm.v12i1.2162
  14. Bacci JL, Zaraa S, Stergachis A, Simic G, White HS. Community pharmacists' role in caring for people living with epilepsy: a scoping review. Epilepsy Behav 2021;117:107850. https://doi.org/10.1016/j.yebeh.2021.107850
  15. Ratanajamit C, Kaewpibal P, Setthawacharavanich S, Faroongsarng D. Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. J Med Assoc Thai 2009;92(11):1500-1507.
  16. Ernawati I, Islamiyah WR, Sumarno. How to improve clinical outcome of epileptic seizure control based on medication adherence? A literature review. Open Access Maced J Med Sci 2018;6(6):1174-1179. https://doi.org/10.3889/oamjms.2018.235
  17. Reis TM, Campos M, Nagai MM, Pereira L. Contributions of pharmacists in the treatment of epilepsy: a systematic review. Am J Pharm Benefits 2016;8(3):e55-e60.
  18. Taube M, Kotloski R, Karasov A, Jones JC, Gidal B. Impact of clinical pharmacists on access to care in an epilepsy clinic. Fed Pract 2022;39(Suppl 1):S5-S9. https://doi.org/10.12788/fp.0252
  19. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc 2015;13(3):141-146. https://doi.org/10.1097/XEB.0000000000000050
  20. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018;169(7):467-473. https://doi.org/10.7326/M18-0850
  21. Fogg A, Staufenberg EF, Small I, Bhattacharya D. An exploratory study of primary care pharmacist-led epilepsy consultations. Int J Pharm Pract 2012;20(5):294-302. https://doi.org/10.1111/j.2042-7174.2012.00207.x
  22. Tang F, Zhu G, Jiao Z, Ma C, Chen N, Wang B. The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy Behav 2014;37:157-164. https://doi.org/10.1016/j.yebeh.2014.05.017
  23. Li WS, Ye CC, Sulaiman N, Rahman HM, Mun NK. The impact of epilepsy review service on seizure control in primary care. Pharm Res Rep 2018;1:32-41.
  24. Jinil AL, Bharathi DR, Nataraj GR, Daniel M. Impact of counseling on patient caretaker's knowledge and medication adherence to paediatric antiepileptic drug therapy. Int J Sci Healthc Res 2018;3(4):158-165.
  25. Ma M, Peng Q, Gu X, Hu Y, Sun S, Sheng Y, et al. Pharmacist impact on adherence of valproic acid therapy in pediatric patients with epilepsy using active education techniques. Epilepsy Behav 2019;98(Pt A):14-18. https://doi.org/10.1016/j.yebeh.2019.06.003
  26. Zheng Y, Ding X, Guo Y, Chen Q, Wang W, Zheng Y, et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy Behav 2019;100(Pt A):106400. https://doi.org/10.1016/j.yebeh.2019.07.001
  27. Chandrasekhar D, Mohanlal SP, Mathew AC, Hashik PM. Impact of clinical pharmacist managed patient counselling on the knowledge and adherence to antiepileptic drug therapy. Clin Epidemiol Glob Health 2020;8(4):1242-1247. https://doi.org/10.1016/j.cegh.2020.04.021
  28. Jarad S, Akour A, Khreisat WH, Elshammari AK, Madae'en S. The role of clinical pharmacist in pediatrics' adherence to antiepileptic drugs. J Pharm Technol 2022;38(5):272-282. https://doi.org/10.1177/87551225221097619
  29. Tamilselvan T, Menon AG, Vijayan AS, Pradosh A, Thomas H. Impact of pharmacist assisted patient counselling in improving medication adherence and quality of life in epileptic patients. Sch J App Med Sci 2022;10(6):1012-1015. https://doi.org/10.36347/sjams.2022.v10i06.023
  30. Ozdag E, Firat O, Coban Taskin A, Uludag IF, Sener U, Demirkan K. Pharmacist's impact on medication adherence and drugrelated problems in patients with epilepsy. Turk J Pharm Sci 2024;20(6):361-367. https://doi.org/10.4274/tjps.galenos.2023.36080
  31. Haut SR, Gursky JM, Privitera M. Behavioral interventions in epilepsy. Curr Opin Neurol 2019;32(2):227-236. https://doi.org/10.1097/WCO.0000000000000661
  32. Al-Aqeel S, Gershuni O, Al-Sabhan J, Hiligsmann M. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. Cochrane Database Syst Rev 2020;10(10):CD008312. https://doi.org/10.1002/14651858.CD008312.pub4
  33. Yilmazel G. Teachers' negative attitudes and limited health literacy levels as risks for low awareness of epilepsy in Turkey. J Prev Med Public Health 2023;56(6):573-582. https://doi.org/10.3961/jpmph.23.330
  34. Boon P, Ferrao Santos S, Jansen AC, Lagae L, Legros B, Weckhuysen S. Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update. Acta Neurol Belg 2021;121(1):241-257. https://doi.org/10.1007/s13760-020-01488-y
  35. Marawar R, Faraj M, Lucas K, Burns CV, Garwood CL. Implementation of an older adult epilepsy clinic utilizing pharmacist services. J Am Pharm Assoc (2003) 2021;61(6):e93-e98. https://doi.org/10.1016/j.japh.2021.07.003
  36. Eshiet UI, Okonta JM, Ukwe CV. Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy: a randomized controlled trial. Epilepsy Res 2021;174:106648. https://doi.org/10.1016/j.eplepsyres.2021.106648
  37. Michaelis R, Tang V, Wagner JL, Modi AC, LaFrance WC Jr, Goldstein LH, et al. Psychological treatments for people with epilepsy. Cochrane Database Syst Rev 2017;10(10):CD012081. https://doi.org/10.1002/14651858.CD012081.pub2
  38. Pandey DK, Levy J, Serafini A, Habibi M, Song W, Shafer PO, et al. Self-management skills and behaviors, self-efficacy, and quality of life in people with epilepsy from underserved populations. Epilepsy Behav 2019;98(Pt A):258-265. https://doi.org/10.1016/j.yebeh.2019.07.042
  39. Belayneh Z, Mekuriaw B. A systematic review and meta-analysis of anti-epileptic medication non-adherence among people with epilepsy in Ethiopia. Arch Public Health 2020;78:23. https://doi.org/10.1186/s13690-020-00405-2
  40. Niriayo YL, Mamo A, Kassa TD, Asgedom SW, Atey TM, Gidey K, et al. Treatment outcome and associated factors among patients with epilepsy. Sci Rep 2018;8(1):17354. https://doi.org/10.1038/s41598-018-35906-2
  41. Paschal AM, Hawley SR, St Romain T, Ablah E. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia 2008;49(7):1115-1122. https://doi.org/10.1111/j.1528-1167.2008.01645.x